secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001104659-23-088326
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.02, 3.03
LLM model:  deepseek-v4-flash:cloud@v2

iBio preliminary FY2023 net loss $29-29.5M; cash drops to $7.6M; warrants repriced to $0.50
--------------------------------------------------------------------------------

- Preliminary FY2023 net loss from continuing ops expected $29.0M-$29.5M vs $29.6M prior year.
- Cash at June 30, 2023: $7.6M (incl $3.3M restricted) down from $28.7M (incl $6M) year ago.
- Common shares outstanding increased to ~22.4M from 8.7M year ago.
- Term note principal balance reduced to ~$13.1M from $22.4M.
- Amended exercise price of Series A and B warrants (covering ~5.5M shares) to $0.50 from $1.04.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/0001104659-23-088326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/tm2322961d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-088326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer